MetLife Investment Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Hold |
27,787
| – | – | 0.01% | 1214 |
|
|
2025
Q1 | $761K | Sell |
27,787
-424
| -2% | -$11.6K | ﹤0.01% | 1498 |
|
|
2024
Q4 | $1.13M | Buy |
28,211
+2,323
| +9% | +$93.5K | 0.01% | 1347 |
|
|
2024
Q3 | $1.23M | Hold |
25,888
| – | – | 0.01% | 1277 |
|
|
2024
Q2 | $773K | Buy |
25,888
+5,134
| +25% | +$153K | ﹤0.01% | 1491 |
|
|
2024
Q1 | $834K | Buy |
20,754
+789
| +4% | +$31.7K | 0.01% | 1399 |
|
|
2023
Q4 | $508K | Hold |
19,965
| – | – | ﹤0.01% | 1674 |
|
|
2023
Q3 | $278K | Hold |
19,965
| – | – | ﹤0.01% | 2004 |
|
|
2023
Q2 | $459K | Hold |
19,965
| – | – | ﹤0.01% | 1753 |
|
|
2023
Q1 | $592K | Hold |
19,965
| – | – | ﹤0.01% | 1541 |
|
|
2022
Q4 | $498K | Sell |
19,965
-2,273
| -10% | -$56.7K | ﹤0.01% | 1650 |
|
|
2022
Q3 | $484K | Buy |
22,238
+3,010
| +16% | +$65.5K | ﹤0.01% | 1659 |
|
|
2022
Q2 | $379K | Hold |
19,228
| – | – | ﹤0.01% | 1856 |
|
|
2022
Q1 | $814K | Buy |
19,228
+6,981
| +57% | +$295K | 0.01% | 1464 |
|
|
2021
Q4 | $778K | Hold |
12,247
| – | – | 0.01% | 1247 |
|
|
2021
Q3 | $719K | Buy |
12,247
+1,063
| +10% | +$62.4K | 0.01% | 1311 |
|
|
2021
Q2 | $542K | Buy |
11,184
+6,635
| +146% | +$322K | ﹤0.01% | 1522 |
|
|
2021
Q1 | $177K | Hold |
4,549
| – | – | ﹤0.01% | 2122 |
|
|
2020
Q4 | $282K | Buy |
+4,549
| New | +$282K | ﹤0.01% | 1799 |
|